UK Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Vehicles & Parts
Aston Martin Lagonda Global Holdings PLC (AMGDF) Q3 2024 Earnings Call Highlights: Strong Demand Amid Supply Chain Challenges
Despite a 14% increase in wholesale volumes and positive reception for new models, Aston Martin faces liquidity concerns and supply chain volatility. Oct 31, 2024
GuruFocus News Medical Devices & Instruments
LivaNova PLC (LIVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
LivaNova PLC (LIVN) reports robust double-digit revenue growth, driven by Cardiopulmonary demand, while navigating supply constraints and increased R&D investments. Oct 31, 2024
GuruFocus News Drug Manufacturers
GSK PLC (GSK) Q3 2024 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine Sales Challenges
GSK PLC (GSK) reports robust year-to-date sales growth, driven by Specialty Medicines, while navigating vaccine sales declines and macroeconomic pressures. Oct 31, 2024